Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 193

1.

Metformin improves diastolic function in an HFpEF-like mouse model by increasing titin compliance.

Slater RE, Strom JG, Methawasin M, Liss M, Gotthardt M, Sweitzer N, Granzier HL.

J Gen Physiol. 2019 Jan 7;151(1):42-52. doi: 10.1085/jgp.201812259. Epub 2018 Dec 19.

2.

Higher baseline dietary fat and fatty acid intake is associated with increased risk of incident prostate cancer in the SABOR study.

Liss MA, Al-Bayati O, Gelfond J, Goros M, Ullevig S, DiGiovanni J, Hamilton-Reeves J, O'Keefe D, Bacich D, Weaver B, Leach R, Thompson IM.

Prostate Cancer Prostatic Dis. 2018 Nov 1. doi: 10.1038/s41391-018-0105-2. [Epub ahead of print]

PMID:
30385837
3.

Immunogenic Heterogeneity of Renal Cell Carcinoma With Venous Tumor Thrombus.

Liss MA, Chen Y, Rodriguez R, Pruthi D, Johnson-Pais T, Wang H, Mansour A, Kaushik D.

Urology. 2018 Oct 29. pii: S0090-4295(18)31050-1. doi: 10.1016/j.urology.2018.09.018. [Epub ahead of print]

PMID:
30385260
4.

The effect of 3-month finasteride challenge on biomarkers for predicting cancer outcome on biopsy: Results of a randomized trial.

Hernandez J, Gelfond J, Goros M, Liss MA, Liang Y, Ankerst D, Thompson IM Jr, Leach RJ.

PLoS One. 2018 Oct 9;13(10):e0204823. doi: 10.1371/journal.pone.0204823. eCollection 2018.

5.

Quality and Quantity in Kidney Cancer Surgery: The Role of Nonneoplastic Kidney and Kidney Volumetrics in Predicting Postoperative Renal Function.

Pruthi DK, Oomah S, Lu V, Ting T, Knickle C, Liss MA, Gibson IW, Kirkpatrick IDC, McGregor TB.

Am J Clin Pathol. 2019 Jan 1;151(1):108-115. doi: 10.1093/ajcp/aqy107.

PMID:
30212840
6.

Outcomes of Genitourinary Injury in U.S. Iraq and Afghanistan War Veterans Receiving Care from the Veterans Health Administration.

Nnamani NS, Pugh MJ, Amuan ME, Eapen BC, Hudak SJ, Liss MA, Orman JA.

Mil Med. 2018 Aug 14. doi: 10.1093/milmed/usy196. [Epub ahead of print]

PMID:
30124961
7.

mTOR inhibitors for treatment of low-risk prostate cancer.

Liss MA, Rickborn L, DiGiovanni J, Bacich D, DeGraffenried LA, Parihar M, Thompson IM, Sharp ZD.

Med Hypotheses. 2018 Aug;117:63-68. doi: 10.1016/j.mehy.2018.06.004. Epub 2018 Jun 5.

PMID:
30077200
8.

Metabolic Biosynthesis Pathways Identified from Fecal Microbiome Associated with Prostate Cancer.

Liss MA, White JR, Goros M, Gelfond J, Leach R, Johnson-Pais T, Lai Z, Rourke E, Basler J, Ankerst D, Shah DP.

Eur Urol. 2018 Nov;74(5):575-582. doi: 10.1016/j.eururo.2018.06.033. Epub 2018 Jul 12.

PMID:
30007819
9.

Drug discovery with an RBM20 dependent titin splice reporter identifies cardenolides as lead structures to improve cardiac filling.

Liss M, Radke MH, Eckhard J, Neuenschwander M, Dauksaite V, von Kries JP, Gotthardt M.

PLoS One. 2018 Jun 11;13(6):e0198492. doi: 10.1371/journal.pone.0198492. eCollection 2018.

10.

Contemporary surgical outcomes of venous tumour thrombectomy managed with intraoperative Doppler ultrasound for kidney cancer.

Pruthi DK, Wang H, Satsangi A, Cajipe M, Iffrig K, Haidar GM, Hicks T, Sako EY, Liss MA, Chowdhury WH, Rodriguez R, Kaushik D.

Can Urol Assoc J. 2018 May 14. doi: 10.5489/cuaj.5013. [Epub ahead of print]

11.

Modifiable risk factors to reduce renal cell carcinoma incidence: Insight from the PLCO trial.

Gelfond J, Al-Bayati O, Kabra A, Iffrig K, Kaushik D, Liss MA.

Urol Oncol. 2018 Jul;36(7):340.e1-340.e6. doi: 10.1016/j.urolonc.2018.04.011. Epub 2018 May 17.

PMID:
29779672
12.

A Contemporary Prostate Biopsy Risk Calculator Based on Multiple Heterogeneous Cohorts.

Ankerst DP, Straubinger J, Selig K, Guerrios L, De Hoedt A, Hernandez J, Liss MA, Leach RJ, Freedland SJ, Kattan MW, Nam R, Haese A, Montorsi F, Boorjian SA, Cooperberg MR, Poyet C, Vertosick E, Vickers AJ.

Eur Urol. 2018 Aug;74(2):197-203. doi: 10.1016/j.eururo.2018.05.003. Epub 2018 May 16.

PMID:
29778349
13.

Targeted Antimicrobial Prophylaxis Does Not Always Prevent Sepsis after Transrectal Prostate Biopsy.

Jiang P, Liss MA, Szabo RJ.

J Urol. 2018 Aug;200(2):361-368. doi: 10.1016/j.juro.2018.03.078. Epub 2018 Mar 21.

PMID:
29574110
14.

The effectiveness of targeted relative to empiric prophylaxis on infectious complications after transrectal ultrasound-guided prostate biopsy: a meta-analysis.

Scott S, Harris PN, Williamson DA, Liss MA, Doi SAR, Roberts MJ.

World J Urol. 2018 Jul;36(7):1007-1017. doi: 10.1007/s00345-018-2217-7. Epub 2018 Feb 16. Review.

15.

Incorporation of Urinary Prostate Cancer Antigen 3 and TMPRSS2:ERG into Prostate Cancer Prevention Trial Risk Calculator.

Ankerst DP, Goros M, Tomlins SA, Patil D, Feng Z, Wei JT, Sanda MG, Gelfond J, Thompson IM, Leach RJ, Liss MA.

Eur Urol Focus. 2018 Feb 5. pii: S2405-4569(18)30011-7. doi: 10.1016/j.euf.2018.01.010. [Epub ahead of print]

PMID:
29422418
16.

Improving risk stratification among veterans diagnosed with prostate cancer: impact of the 17-gene prostate score assay.

Lynch JA, Rothney MP, Salup RR, Ercole CE, Mathur SC, Duchene DA, Basler JW, Hernandez J, Liss MA, Porter MP, Wright JL, Risk MC, Garzotto M, Efimova O, Barrett L, Berse B, Kemeter MJ, Febbo PG, Dash A.

Am J Manag Care. 2018 Jan;24(1 Suppl):S4-S10.

17.

Chemoprevention in Prostate Cancer: Current Perspective and Future Directions.

Rivero JR Jr, Thompson IM Jr, Liss MA, Kaushik D.

Cold Spring Harb Perspect Med. 2018 Oct 1;8(10). pii: a030494. doi: 10.1101/cshperspect.a030494. Review.

PMID:
29311128
18.

Physical Activity Decreases Kidney Cancer Mortality.

Liss M, Natarajan L, Hasan A, Noguchi JL, White M, Parsons JK.

Curr Urol. 2017 Nov;10(4):193-198. doi: 10.1159/000447180. Epub 2017 Oct 22.

19.

Single-Cell RNA-seq Reveals a Subpopulation of Prostate Cancer Cells with Enhanced Cell-Cycle-Related Transcription and Attenuated Androgen Response.

Horning AM, Wang Y, Lin CK, Louie AD, Jadhav RR, Hung CN, Wang CM, Lin CL, Kirma NB, Liss MA, Kumar AP, Sun L, Liu Z, Chao WT, Wang Q, Jin VX, Chen CL, Huang TH.

Cancer Res. 2018 Feb 15;78(4):853-864. doi: 10.1158/0008-5472.CAN-17-1924. Epub 2017 Dec 12.

PMID:
29233929
20.

Partial Nephrectomy versus Thermal Ablation for Clinical Stage T1 Renal Masses: Systematic Review and Meta-Analysis of More than 3,900 Patients.

Rivero JR, De La Cerda J 3rd, Wang H, Liss MA, Farrell AM, Rodriguez R, Suri R, Kaushik D.

J Vasc Interv Radiol. 2018 Jan;29(1):18-29. doi: 10.1016/j.jvir.2017.08.013. Review.

PMID:
29102464
21.

Prostate cancer prevention with 5-alpha reductase inhibitors: concepts and controversies.

Liss MA, Thompson IM.

Curr Opin Urol. 2018 Jan;28(1):42-45. doi: 10.1097/MOU.0000000000000464. Review.

PMID:
29095730
22.

Clinical genetics and outcome of left ventricular non-compaction cardiomyopathy.

Sedaghat-Hamedani F, Haas J, Zhu F, Geier C, Kayvanpour E, Liss M, Lai A, Frese K, Pribe-Wolferts R, Amr A, Li DT, Samani OS, Carstensen A, Bordalo DM, Müller M, Fischer C, Shao J, Wang J, Nie M, Yuan L, Haßfeld S, Schwartz C, Zhou M, Zhou Z, Shu Y, Wang M, Huang K, Zeng Q, Cheng L, Fehlmann T, Ehlermann P, Keller A, Dieterich C, Streckfuß-Bömeke K, Liao Y, Gotthardt M, Katus HA, Meder B.

Eur Heart J. 2017 Dec 7;38(46):3449-3460. doi: 10.1093/eurheartj/ehx545.

PMID:
29029073
23.

Rational antibiotic sustainability for transrectal prostate biopsy prophylaxis.

Pruthi DK, Liss MA.

Nat Rev Urol. 2017 Nov;14(11):696. doi: 10.1038/nrurol.2017.158. Epub 2017 Oct 4. No abstract available.

PMID:
28976502
24.

Effects of Obesity on the Regulation of Macrophage Population in the Prostate Tumor Microenvironment.

Galván GC, Johnson CB, Price RS, Liss MA, Jolly CA, deGraffenried LA.

Nutr Cancer. 2017 Oct;69(7):996-1002. doi: 10.1080/01635581.2017.1359320. Epub 2017 Sep 25.

PMID:
28945110
25.

Sepsis: Prophylactic antibiotic for prostate biopsy: the carbapenem gamble.

Pruthi DK, Liss MA.

Nat Rev Urol. 2017 Jul;14(7):394-396. doi: 10.1038/nrurol.2017.73. Epub 2017 May 23. No abstract available.

PMID:
28534539
26.

An Update of the American Urological Association White Paper on the Prevention and Treatment of the More Common Complications Related to Prostate Biopsy.

Liss MA, Ehdaie B, Loeb S, Meng MV, Raman JD, Spears V, Stroup SP.

J Urol. 2017 Aug;198(2):329-334. doi: 10.1016/j.juro.2017.01.103. Epub 2017 Mar 29.

PMID:
28363690
27.

Hormonal manipulation with finasteride or oral contraception does not influence incidence of renal cell carcinoma.

Kabra A, Gelfond J, Liss MA.

Eur J Cancer Prev. 2018 Sep;27(5):449-452. doi: 10.1097/CEJ.0000000000000345.

PMID:
28338531
28.

Radical Cystectomy Compared to Combined Modality Treatment for Muscle-Invasive Bladder Cancer: A Systematic Review and Meta-Analysis.

Vashistha V, Wang H, Mazzone A, Liss MA, Svatek RS, Schleicher M, Kaushik D.

Int J Radiat Oncol Biol Phys. 2017 Apr 1;97(5):1002-1020. doi: 10.1016/j.ijrobp.2016.11.056. Epub 2016 Dec 13. Review.

PMID:
28332983
29.

Comparison of laparoendoscopic single-site (LESS) and multiport laparoscopic radical nephrectomy for clinical T1b and T2a renal masses.

Hassan AR, Raheem OA, Berquist S, Beksac AT, Bloch A, Field C, Lee HJ, Mehrazin R, Holden M, McDonald M, Hamilton Z, Liss M, Derweesh IH.

Minerva Urol Nefrol. 2017 Dec;69(6):596-603. doi: 10.23736/S0393-2249.17.02785-0. Epub 2017 Mar 10.

30.

Novel Definitions of Low-risk and High-risk Prostate Cancer: Implications for the European Randomized Study of Screening for Prostate Cancer Risk Assessment Tool.

Pruthi DK, Ankerst DP, Liss MA.

Eur Urol. 2017 Jul;72(1):52-53. doi: 10.1016/j.eururo.2017.02.009. Epub 2017 Feb 17. No abstract available.

PMID:
28222931
31.

Validation of 3D volumetric-based renal function prediction calculator for nephron sparing surgery.

Corradi R, Kabra A, Suarez M, Oppenheimer J, Okhunov Z, White H, Nougaret S, Vargas HA, Landman J, Coleman J, Liss MA.

Int Urol Nephrol. 2017 Apr;49(4):615-621. doi: 10.1007/s11255-017-1525-y. Epub 2017 Feb 4.

32.

Exercise Decreases and Smoking Increases Bladder Cancer Mortality.

Liss MA, White M, Natarajan L, Parsons JK.

Clin Genitourin Cancer. 2017 Jun;15(3):391-395. doi: 10.1016/j.clgc.2016.11.006. Epub 2016 Dec 1.

33.

Erratum to "Primary Desmoplastic Melanoma of the Penis".

Chu JT, Liss MA, Wu WW, Dash A, Lu D.

Case Rep Urol. 2016;2016:3181869. Epub 2016 Oct 25.

34.

TGF-β signal rewiring sustains epithelial-mesenchymal transition of circulating tumor cells in prostate cancer xenograft hosts.

Huang G, Osmulski PA, Bouamar H, Mahalingam D, Lin CL, Liss MA, Kumar AP, Chen CL, Thompson IM, Sun LZ, Gaczynska ME, Huang TH.

Oncotarget. 2016 Nov 22;7(47):77124-77137. doi: 10.18632/oncotarget.12808.

35.

Weight Loss Following Radical Cystectomy for Bladder Cancer: Characterization and Effect on Survival.

McDonald ML, Liss MA, Nseyo UU, Gal DB, Kane CJ, Kader AK.

Clin Genitourin Cancer. 2017 Feb;15(1):86-92. doi: 10.1016/j.clgc.2016.06.009. Epub 2016 Jun 23.

PMID:
27460433
36.

Radiologic indicators prior to renal cell cancer thrombectomy: Implications for vascular reconstruction and mortality.

Overholser S, Raheem O, Zapata D, Kaushik D, Rodriguez R, Derweesh IH, Liss MA.

Urol Ann. 2016 Jul-Sep;8(3):312-6. doi: 10.4103/0974-7796.184888.

37.

A diagnosis of prostate cancer and pursuit of active surveillance is not followed by weight loss: potential for a teachable moment.

Liss MA, Schenk JM, Faino AV, Newcomb LF, Boyer H, Brooks JD, Carroll PR, Dash A, Fabrizio MD, Gleave ME, Nelson PS, Neuhouser ML, Wei JT, Zheng Y, Wright JL, Lin DW, Thompson IM.

Prostate Cancer Prostatic Dis. 2016 Dec;19(4):390-394. doi: 10.1038/pcan.2016.28. Epub 2016 Jul 19.

38.

Risk factors for infectious readmissions following radical cystectomy: results from a prospective multicenter dataset.

Hemal S, Krane LS, Richards KA, Liss M, Kader AK, Davis RL 3rd.

Ther Adv Urol. 2016 Jun;8(3):167-74. doi: 10.1177/1756287216636996. Epub 2016 Mar 8.

39.

Does timing of targeted therapy for metastatic renal cell carcinoma impact treatment toxicity and surgical complications? A comparison of primary and adjuvant approaches.

Patel N, Woo J, Liss MA, Palazzi KL, Randall JM, Mehrazin R, Jabaj R, Mirheydar HS, Gillis K, Lee HJ, Patterson AL, Kane CJ, Millard F, Derweesh IH.

Can J Urol. 2016 Apr;23(2):8227-33.

PMID:
27085828
40.

Restriction spectrum imaging improves MRI-based prostate cancer detection.

McCammack KC, Schenker-Ahmed NM, White NS, Best SR, Marks RM, Heimbigner J, Kane CJ, Parsons JK, Kuperman JM, Bartsch H, Desikan RS, Rakow-Penner RA, Liss MA, Margolis DJ, Raman SS, Shabaik A, Dale AM, Karow DS.

Abdom Radiol (NY). 2016 May;41(5):946-53. doi: 10.1007/s00261-016-0659-1.

41.

In vivo prostate cancer detection and grading using restriction spectrum imaging-MRI.

McCammack KC, Kane CJ, Parsons JK, White NS, Schenker-Ahmed NM, Kuperman JM, Bartsch H, Desikan RS, Rakow-Penner RA, Adams D, Liss MA, Mattrey RF, Bradley WG, Margolis DJ, Raman SS, Shabaik A, Dale AM, Karow DS.

Prostate Cancer Prostatic Dis. 2016 Jun;19(2):168-73. doi: 10.1038/pcan.2015.61. Epub 2016 Jan 12.

42.

Association of rise in C-reactive protein with decline in renal function following partial nephrectomy.

Cohen SA, Kopp RP, Palazzi KL, Liss MA, Mehrazin R, Woo J, Lee HJ, Jabaji R, Gillis K, Wang S, Wake RW, Patterson AL, Derweesh IH.

Can J Urol. 2015 Dec;22(6):8085-92.

PMID:
26688138
43.

Primary Desmoplastic Melanoma of the Penis.

Chu JT, Liss MA, Wu WW, Dash A, Lu D.

Case Rep Urol. 2015;2015:706572. doi: 10.1155/2015/706572. Epub 2015 Nov 3. Erratum in: Case Rep Urol. 2016;2016:3181869.

44.

A case control study of sarcosine as an early prostate cancer detection biomarker.

Ankerst DP, Liss M, Zapata D, Hoefler J, Thompson IM, Leach RJ.

BMC Urol. 2015 Oct 1;15:99. doi: 10.1186/s12894-015-0095-5.

45.

Finasteride Reduces Risk of Bladder Cancer in a Large Prospective Screening Study.

Morales EE, Grill S, Svatek RS, Kaushik D, Thompson IM Jr, Ankerst DP, Liss MA.

Eur Urol. 2016 Mar;69(3):407-10. doi: 10.1016/j.eururo.2015.08.029. Epub 2015 Aug 28.

PMID:
26320383
46.

Obesity, Physical Activity and Bladder Cancer.

Noguchi JL, Liss MA, Parsons JK.

Curr Urol Rep. 2015 Oct;16(10):74. doi: 10.1007/s11934-015-0546-2. Review.

PMID:
26303776
47.

Rapid Identification of Rectal Multidrug-resistant Escherichia coli Before Transrectal Prostate Biopsy.

Tchesnokova VL, Ottley LL, Sakamoto K, Fierer J, Sokurenko E, Liss MA.

Urology. 2015 Dec;86(6):1200-5. doi: 10.1016/j.urology.2015.07.008. Epub 2015 Aug 20.

48.

Prostate diffusion imaging with distortion correction.

Rakow-Penner RA, White NS, Margolis DJA, Parsons JK, Schenker-Ahmed N, Kuperman JM, Bartsch H, Choi HW, Bradley WG, Shabaik A, Huang J, Liss MA, Marks L, Kane CJ, Reiter RE, Raman SS, Karow DS, Dale AM.

Magn Reson Imaging. 2015 Nov;33(9):1178-1181. doi: 10.1016/j.mri.2015.07.006. Epub 2015 Jul 26.

49.

Parenchymal Volumetric Assessment as a Predictive Tool to Determine Renal Function Benefit of Nephron-Sparing Surgery Compared with Radical Nephrectomy.

Liss MA, DeConde R, Caovan D, Hofler J, Gabe M, Palazzi KL, Patel ND, Lee HJ, Ideker T, Van Poppel H, Karow D, Aertsen M, Casola G, Derweesh IH.

J Endourol. 2016 Jan;30(1):114-21. doi: 10.1089/end.2015.0411. Epub 2015 Sep 25.

50.

Analysis of Renal Functional Outcomes After Radical or Partial Nephrectomy for Renal Masses ≥7 cm Using the RENAL Score.

Kopp RP, Liss MA, Mehrazin R, Wang S, Lee HJ, Jabaji R, Mirheydar HS, Gillis K, Patel N, Palazzi KL, Wan JY, Patterson AL, Derweesh IH.

Urology. 2015 Aug;86(2):312-9. doi: 10.1016/j.urology.2015.02.067. Epub 2015 Jul 16.

PMID:
26189330

Supplemental Content

Support Center